ABF Ingredients (ABFI) has acquired Fytexia Group, a developer of active ingredients for dietary supplements. The acquisition will expand ABFI’s portfolio of products and capabilities in the pharmaceutical, nutritional and food market sectors.
Headquartered in France, with presence in Europe and regional offices in the US and Asia, Fytexia will help positioned to serve customers globally. It focuses on the research and scientific validation of bioactive compounds to deliver functional ingredients targeting non-communicable diseases. The company comprises two businesses, Fytexia, a producer in polyphenols, and B Natural, which extracts and refines brown propolis.
“Fytexia Group is a strong science driven business with a successful track record servicing the dietary supplements industry. Fytexia Group will make an excellent addition to our family of businesses by bringing expertise in polyphenols and health and nutrition active ingredients extracts from botanicals and propolis, therefore strengthening the ABFI offering in health and nutrition ingredients,” said Fabienne Saadane-Oaks, CEO of ABFI.
“We are very excited to join ABFI. We share the same values and are both convinced that natural science based nutritional solutions are the future of the industry. At Fytexia Group, we believe ABFI is the perfect partner to accelerate the development of our activity globally in the best possible conditions, with the support of a larger organisation. Therefore, we will accelerate our clinical research to support our existing product line as well as our future developments,” said Matthieu Arguillère, CEO of Fytexia Group.